We are live on ! Find out more
PULM icon

Pulmatrix

19 hedge funds and large institutions have $2.65M invested in Pulmatrix in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

19.52% less ownership

Funds ownership: 33.57% → 14.05% (-20%)

30% less funds holding

Funds holding: 27 → 19 (-8)

56% less capital inflows, than outflows

Capital inflows: $672K | Capital outflows: $1.51M

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
19
Holders Change
-8
Holders Change %
-29.63%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
6
Reduced
2
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

PULM Hedge Fund Activity: Q2 2018 in Review

19 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Pulmatrix (PULM) for Q2 2018, worth a combined $2.65M — down 31% from $3.83M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of PULM and 2 opened new positions — a net loss of 8 holders — while 2 trimmed existing stakes and 6 added.

The largest buyer was Polaris Venture Management Co V, adding an estimated $388K. The largest seller was Armistice Capital, exiting entirely with an estimated $835K sold.

  • 19 institutional investors held Pulmatrix (PULM) as of Q2 2018, down from 27 in Q1 2018.
  • Funds reported $2.65M of Pulmatrix stock for Q2 2018, down 31% quarter-over-quarter.
  • 2 funds opened new Pulmatrix positions in Q2 2018 and 10 closed out, a net change of -8 holders.
  • The largest Pulmatrix buyer in Q2 2018 was Polaris Venture Management Co V, an estimated $388K added.
  • The largest Pulmatrix seller in Q2 2018 was Armistice Capital, an estimated $835K sold.

Based on aggregated 13F filings for Q2 2018.